Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Non CNS Tumors × talimogene laherparepvec × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 9 Carcinoma, Squamous Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Non CNS Tumors 1 Adenocarcinoma 1

Interventions

talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02756845 2024-02-20

Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

Amgen

Phase 1 Completed

15 enrolled 13 charts

Advanced Non CNS Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡